FDA to Step Up Role as Driver of Biotech Innovation
By Mari Serebrov
Thursday, October 6, 2011
WASHINGTON Voicing a sense of urgency, FDA Commissioner Margaret Hamburg unveiled a blueprint Wednesday aimed at making the agency a part of the solution, rather than the problem, in promoting innovation in the biotech industry.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.